What is the fair value of Teleflex Incorporated (NYSE-TFX) stock?

The current fair value estimate for Teleflex Incorporated (NYSE-TFX) is $152.74. This implies an estimated upside of 0.4% versus the current market price.

Is Teleflex Incorporated (NYSE-TFX) undervalued or overvalued?

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

What is the analyst price target for NYSE-TFX stock?

The available analyst price target for Teleflex Incorporated (NYSE-TFX) is $154. The analyst target implies estimated upside of 1.2%.

How is the financial health of Teleflex Incorporated?

The current financial health read for Teleflex Incorporated (NYSE-TFX) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Teleflex Incorporated (NYSE-TFX) pay dividends?

Based on the current data, dividend yield is 0.9%.

What is the market capitalization of Teleflex Incorporated?

The current market capitalization listed for Teleflex Incorporated is 6.447 B.

What is the enterprise value of Teleflex Incorporated?

The current enterprise value listed for Teleflex Incorporated is 9.06 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Teleflex Incorporated?

The ticker symbol for Teleflex Incorporated is NYSE-TFX, and the stock is listed on NYSE.

Where is Teleflex Incorporated (NYSE-TFX) listed?

Teleflex Incorporated (NYSE-TFX) is listed on NYSE.

What is the debt-to-total-capital ratio for Teleflex Incorporated?

The current debt-to-total-capital ratio listed for Teleflex Incorporated is 31.6%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Teleflex Incorporated?

The free float listed for Teleflex Incorporated is 99.6%. Free float helps investors understand how much of the share base is available for public trading.

Teleflex Incorporated (TFX) Fair Value & Stock Analysis

Teleflex Incorporated (TFX)

Teleflex Incorporated is a healthcare company that designs, develops, manufactures, and supplies single-use medical devices used in diagnostic and therapeutic procedures, with applications in critical care and surgery. Its portfolio spans vascular and emergency medicine products, including Arrow-branded catheters, intraosseous access systems, catheter navigation tools, and hemostatic products such as QuikClot. The company also provides interventional offerings, including coronary and peripheral devices, structural heart support products, closure systems, and related catheter-based technologies. In addition, Teleflex sells surgical products under brands such as Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS. Its customers include hospitals, healthcare providers, and medical device manufacturers, and it also sells products online. Teleflex was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-TFX	$152.74	0.4% Upside	Fair	$154	1.2% Upside	Fair	Good	0.9%	2.2x	2.9x	6.447 B	9.06 B	31.6%	99.6%	3.9	-5.8%	-1,305.4%